CareFusion is recalling 7,418 units of its Alaris Syringe infusion pump, a corrective action that the FDA just deemed Class 1. This marks CareFusion's ninth Class 1 recall of an Alaris device since ...
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. BD has expanded a Class I Alaris recall to cover 15 ...
FDA has given Class I status to a Carefusion recall related to the Alaris Model 8100 infusion pump. A software failure in the pump had been identified in modules running software version 9.1.18. Last ...
FILE PHOTO: Signage is seen outside of FDA headquarters in White Oak, Maryland (Reuters) -The U.S. Food and Drug Administration (FDA) said on Friday that Becton Dickinson is recalling its Alaris ...
To data, there have been 13 reported injuries. Becton Dickinson (BD)/Carefusion 303 is recalling the Alaris infusion pump due to incompatibility issues with Cardinal Health Monoject syringes. The Food ...
The US Food and Drug Administration (FDA) has notified healthcare providers of a class 1 recall of CareFusion's Alaris PC unit (model 8015) with software version 9.12. The Alaris PC unit is the ...
FDA has assigned a Class I designation to a recall of CareFusion Alaris infusion pumps, originally announced last month. The agency gave the same designation to a recall of frame membranes that Elite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results